GAM Holding’s GSK GSK Stock Holding History

GAM Holding’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-109,691	Closed	-$5.97M	–	243
2022 Q2	$5.97M	Sell	109,691 -981	-0.9%	-$54.2K	0.4%	79
2022 Q1	$6.03M	Buy	110,672 +24,074	+28%	+$1.31M	0.3%	99
2021 Q4	$4.77M	Sell	86,598 -46	-0.1%	-$2.39K	0.21%	118
2021 Q3	$4.14M	Hold	86,644	–	–	0.19%	122
2021 Q2	$4.31M	Sell	86,644 -252	-0.3%	-$12.1K	0.19%	136
2021 Q1	$3.88M	Buy	86,896 +141	+0.2%	+$6.4K	0.18%	151
2020 Q4	$3.99M	Hold	86,755	–	–	0.24%	116
2020 Q3	$4.08M	Sell	86,755 -127	-0.1%	-$6.36K	0.25%	128
2020 Q2	$4.43M	Sell	86,882 -207	-0.2%	-$10.6K	0.28%	107
2020 Q1	$4.13M	Buy	+87,089	New	+$4.65M	0.28%	105
2017 Q3	–	Sell	-20,814	Closed	-$1.12M	–	701
2017 Q2	$1.12M	Buy	20,814 +4,372	+27%	+$233K	0.02%	613
2017 Q1	$867K	Buy	16,442 +6,372	+63%	+$323K	0.01%	684
2016 Q4	$485K	Buy	+10,070	New	+$497K	0.01%	760

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GAM Holding's GSK Position: Q3 2022 in Review

GAM Holding sold out of GSK (GSK) in Q3 2022, closing a stake of 109,691 shares — an estimated $5.97M sold.

GAM Holding first reported a position in GSK in Q4 2016 and held it in 13 quarters. The position peaked at $6.03M in Q1 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

GAM Holding reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
GAM Holding sold 109,691 GSK shares in Q3 2022, an estimated $5.97M.
GAM Holding first reported a position in GSK in Q4 2016 and held it in 13 quarters.
GAM Holding's GSK position peaked at $6.03M in Q1 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on GAM Holding's 13F filing for Q3 2022, filed 19 Oct 2022.